STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
President & CEO Tomas Puusepp comments:
”In the third quarter of fiscal year 2007/08, we saw a continued strong demand. Order intake for the first 9 months increased by 10 percent in local currency, driven primarily by a continued success in radiation therapy in North America, a stronger interest in Leksell Gamma Knife® in Europe and a strong recovery on the Chinese market. Order bookings for the third quarter in isolation, shows moderate growth in local currency, explained by the large European orders that were received in the comparison quarter.
